← Questions & Perspectives

Ketogenic Diet and Hyperbaric Oxygen: Why Combine Them?

Research Note · English ·

Angela Poff and colleagues investigated whether two metabolic interventions together could be more effective against metastatic cancer than either intervention alone.

Blood glucose (A) and tumor growth (B) in the illustrated treatment groups: control, ketogenic diet (KD), KD with ketone ester (KE), and KD + KE with hyperbaric oxygen therapy (HBOT). These panels show different outcomes and treatment groups from the 2013 survival comparison discussed below.
Blood glucose (A) and tumor growth (B) in the illustrated treatment groups: control, ketogenic diet (KD), KD with ketone ester (KE), and KD + KE with hyperbaric oxygen therapy (HBOT). These panels show different outcomes and treatment groups from the 2013 survival comparison discussed below.

In a 2013 VM-M3 mouse study, ketogenic diet (KD) alone increased mean survival by 56.7% compared with controls. Combining KD with hyperbaric oxygen therapy (HBOT) increased mean survival by 77.9%. HBOT alone did not significantly slow tumor progression.

That difference raises a straightforward question: can interventions acting on distinct aspects of tumor metabolism strengthen one another? KD changes systemic fuel availability. HBOT changes oxygen exposure. The combination produced a stronger result in this mouse model than either approach alone.

The image also illustrates a later experimental interest in ketone esters (KE), which should not be confused with the KD-versus-HBOT survival percentages. These findings are from experimental mouse models and do not establish a cancer treatment for patients.

Source: Poff et al. (2013), PLOS ONE, doi:10.1371/journal.pone.0065522.